• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Market for Point of Care (POC) Diagnostics, 2014-2019

$1,995.00 – $3,995.00

Clear
SKU: KLI5573392 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Pages: 354
  • Description
  • Table of Contents
  • Latest reports

Description

The World Market for Point of Care (POC) Diagnostics

Visit our ‘Point of Care Testing’ curated page for complete industry coverage.

Clinical diagnostic tests performed outside the central laboratory or decentralized testing are generally known as point of care (POC) diagnostic tests. The increasing introduction of transportable, portable, and handheld diagnostic instruments has resulted in the migration of point of care diagnostic testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics.
Who are the top POC diagnostic companies in the healthcare industry? What types of point of care diagnostic testing is selling fastest?  What disease areas will drive near-patient testing forward?  Is point of care testing earning its place in clinical practice?  How is home testing progressing? Kalorama Information’s report, The World Market for Point of Care (POC) Diagnostics, presents current analysis of the point of care diagnostics industry and the role it plays in healthcare. Kalorama Information takes an in-depth look at the POC diagnostic testing market, both professional and self-testing.

Discussed Point of Care Diagnostic Testing Market Segments:

  • Blood Glucose Tests
  • Blood and Electrolytes Testing Market
  • Rapid Coagulation
  • Rapid Cardiac Markers
  • Substance Abuse Testing
  • Pregnancy and Fertility Testing
  • Colon Cancer Screening/Fecal Occult Blood Testing
  • Infectious Disease Testing
  • Cholesterol Testing
  • Cancer Testing
  • Urine Strip Testing
  • Miscellaneous POC Testing
The menu for point-of-care diagnostic testing continues to expand. The traditional set of POC tests includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening. In the past 5-10 years the following tests were added: HgA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP).

Point of care diagnostic testing devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New diagnostic technologies are allowing point of care devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record.

The report’s geographic scope is worldwide with information for specific geographical regions, world demographics, and other general issues affecting the market. All market data pertain to the world market at the manufacturers’ level. The point of care diagnostic testing market includes manufacturer tests excluding services. The base year for data is 2014. Historical data is provided for the years 2012 and 2014, with forecast data provided for 2014 through 2019. Compound annual growth rates (CAGRs) are provided for 2014-2019 periods for each segment covered. Competitive analysis is provided for the year 2014.
The forecasted POC testing market analysis for 2014-2019 is largely based on demographic trends, new developments, innovative technology and global expansion.

 

Point of Care Diagnostic Testing Market Analysis includes:

  • Market Overview
  • Market Analysis by Product Categories
  • Market Analysis by Subcategory: POC Professional Testing, POC Self-Testing
  • Market Analysis by Country: United States, Germany, France, UK, Switzerland, Japan, China, India
  • Market Conclusions
  • Competitive Analysis
  • The World Market for Point of Care (POC) Diagnostics presents the main issues and trends affecting this market, influencing its move into the future. These include:
  • Reimbursement Challenges
  • Competition
  • POC and Biosensors
  • POC Connectivity
  • The Emergence of Non-invasive Technologies

Top and/or innovative POC companies discussed within the report’s Corporate Profiles:

  • Abaxis
  • Abbott Labs
  • Accriva
  • ACON
  • Alere
  • Arkray
  • Beckman Coulter
  • bioMerieux SA
  • Church & Dwight
  • Eiken Chemical
  • EKF Diagnostics
  • Enterix
  • Helena Labs
  • Insight Pharmaceutical
  • Instrumentation Laboratories
  • LifeScan
  • Macherey-Nagel
  • Meridian BioScience
  • Nova Biomedical
  • OPKO Health
  • OraSure
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics
  • Polymer Technologies
  • Quidel
  • Radiometer Medical
  • Response Biomedical
  • Roche Diagnostics
  • Siemens Healthcare
  • Sysmex
  • Trinity Biotech

Methodology

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 30 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

Table of Contents

EXECUTIVE SUMMARY

SCOPE AND METHODOLOGY

Size and Growth of the Market

Key Issues and Trends Affecting Market

Leading Competitors

INTRODUCTION

Point of Care Diagnostics Testing

Industry Regulations

POC Industry Drivers

Patent-Focused Drivers

Medical/Healthcare-Related Drivers

Technology Drivers

Economic Drivers

Other Drivers

POC Test Types

Blood

Urine

Saliva

Hair

Optical Technologies

Breath

CONDITIONS EVALUATED BY POC DIAGNOSTIC TESTING

Cancer

Colorectal Cancer

Prostate Cancer

Cardiovascular Disease

Diabetes

Drug Abuse

Club Drugs

GHB

Rohypnol

Ketamine

Narcotic Abuse

Heroin

Narcotic Analgesics

Opium

Central Nervous System Depressant Abuse

Sedative-Hypnotic/Antianxiety Abuse

Alcohol Abuse

Central Nervous System Stimulants

Amphetamine and Amphetamine-Like Agents

Ecstasy

Cocaine Abuse

Marijuana Abuse

Psychedelic Agents

Tobacco

Inhalant Abuse

Steroid Abuse

Miscellaneous Drugs of Abuse

Salvia

Bath Salts

Khat

DXM

Prevalence and Number of Illicit Drug Users

Infectious Disease

Herpes

HTLV

Respiratory Syncytial Virus

Hepatitis

Lyme Disease

Babesiosis

Gonorrhea, Syphilis and Chlamydia

Trichomonas Vaginalis

HIV/AIDS

Helicobacter Pylori

Influenza

Mononucleosis

Streptococcus

Osteoporosis

Pregnancy and Fertility

World Demographics

Global Aging Population

POC BLOOD GLUCOSE TESTS

Types of Blood Glucose Testing

Fasting Blood Sugar (FBS)

2-Hour Postprandial Blood Sugar (PPBS)

Random Blood Sugar

Glucose Tolerance Test

Glucose Urine Test

Glycated Hemoglobin (HbA1c)

Products

Blood Glucose Self-Testing

Continuous Self-Testing

Glycated Hemoglobin Tests

Professional

Market Size and Growth

POC Glucose Self-Testing

POC Glucose Professional Testing

Competitive Analysis

POC BLOOD AND ELECTROLYTES TESTING MARKET

Types of Blood and Electrolytes Tests

Hemoglobin/Hematocrit

WBC

Blood Gases

Electrolytes

Products

Market Size and Growth

POC Blood and Electrolyte Self-Testing

POC Blood and Electrolyte Professional Testing

Competitive Analysis

RAPID COAGULATION

Products

Platelet Testing

Market Size and Growth

POC Rapid Coagulation Self-Testing

POC Rapid Coagulation Professional Testing

Competitive Analysis

POC RAPID CARDIAC MARKERS

Products

Market Size and Growth

Competitive Analysis

POC SUBSTANCE ABUSE TESTING

Products

Urine

Oral

Blood

Hair

Market Size and Growth

POC Drugs of Abuse Self-Testing

POC Drugs of Abuse Professional Testing

Competitive Analysis

POC PREGNANCY AND FERTILITY TESTING

PRODUCTS

MARKET SIZE AND GROWTH

POC Pregnancy and Fertility Self-Testing

POC Pregnancy and Fertility Professional Testing

Competitive Analysis

POC COLON CANCER SCREENING/FECAL OCCULT BLOOD TESTING141

PRODUCTS

Market Size and Growth

POC Colon Cancer Screening/Fecal Occult Blood Self-Testing

POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing

Competitive Analysis

POC INFECTIOUS DISEASE TESTING

PRODUCTS

MARKET SIZE AND GROWTH

POC Infectious Disease Self-Testing

POC Infectious Disease Professional Testing

Competitive Analysis

POC CHOLESTEROL TESTING

PRODUCTS

POC Cholesterol Self-Testing

POC Cholesterol Professional Testing

Competitive Analysis

POC CANCER TESTING

PRODUCTS

MARKET SIZE AND GROWTH

COMPETITIVE ANALYSIS

POC URINE STRIP TESTING

PRODUCTS

MARKET SIZE AND GROWTH

POC Urine Strip Self-Testing

POC Urine Test Strip Professional Testing

Competitive Analysis

MISCELLANEOUS POC TESTING

Microbiology

TSH

Allergy

Autoimmune

MARKET SIZE AND GROWTH

ISSUES AND TRENDS

Overview

Reimbursement Challenges

Competition

POC and Biosensors and Microfluidics

POC Connectivity

The Emergence of Non-Invasive Technologies

Saliva and Swab

Breath

Optical Techniques

TOTAL GLOBAL POC TESTING MARKET AND COMPETITOR ANALYSIS

Market Overview

Market Analysis by Product Categories

Market Analysis by Subcategory

POC Professional Testing

POC Self-Testing

Market Analysis by Country

United States

Europe

Germany

France

UK

Switzerland

Japan

Rest of World

China

India

Market Conclusions

Conclusion One

Conclusion Two

Conclusion Three

Conclusion Four

Competitive Analysis

SEVENTEEN: CORPORATE PROFILES

Overview

Abaxis, Inc

Company Overview

Product

Performance Review

Abbott Laboratories

Company Overview

Product

Performance Review

Accriva Diagnostics

Company Overview

Products

ACON Laboratories, Inc

Company Overview

Products

Alere Inc

Company Overview

Product

Performance Review

Arkray

Company Overview

Products

Beckman-Coulter, Inc.

Company Overview

Products

Performance Review

bioMerieux SA

Company Overview

Products

Performance Review

Church & Dwight Co., Inc

Company Overview

Products

Eiken Chemical Co Ltd.

Company Overview

Products

EKF Diagnostics GmbH

Company Overview

Products

Performance Review

Enterix, Inc

Company Overview

Products

Helena Laboratories

Company Overview

Products

Insight Pharmaceuticals LLC

Company Overview

Products

Instrumentation Laboratory

Company Overview

Products

LifeScan, Inc

Company Overview

Products

Performance Review

Macherey-Nagel GmbH & Co. KG

Company Overview

Products

Meridian BioScience, Inc

Company Overview

Products

Performance Review

Nova Biomedical, Corp.

Company Overview

Products

Opko Health, Inc

Company Overview

Products

Performance Review

OraSure Technologies, Inc

Company Overview

Products

Performance Review

ORTHO CLINICAL DIAGNOSTICS

Company Overview

Products

POLYMED THERAPEUTICS INC.

Polymedco, Inc

Company Overview

Products

POLYMER TECHNOLOGIES, INC (PTS DIAGNOSTICS)

Company Overview

Products

QUIDEL CORPORATION

Company Overview

Products

Performance Review

RADIOMETER MEDICAL APS

Company Overview

Products

RESPONSE BIOMEDICAL CORP

Company Overview

Products

Performance Review

ROCHE DIAGNOSTICS CORPORATION

Company Overview

Products

Performance Review

SIEMENS HEALTHCARE

Company Overview

Products

Performance Review

SYSMEX CORPORATION

Company Overview

Products

Performance Review

TRINITY BIOTECH PLC

Company Overview

Products

Performance Review

LIST OF COMPANIES

LIST OF TABLES AND FIGURES

ONE: EXECUTIVE SUMMARY

Table 1-1

Global POC Diagnostic Testing Market Analysis: 2012-2019

TWO: INTRODUCTION

Table 2-1

Traditional CLIA-Waived Tests

Table 2-2

Annual CLIA Test Waivers by Selected Analyte(s) (Drugs of Abuse and Therapeutic

Drugs, Urinalysis, Glucose Monitoring, General Chemistry, Infectious Diseases,

Other) (2010-2014)

Table 2-3

CLIA-Waived Tests and Analytes

Table 2-4

2014 CLIA Waivers (Manufacturer and Instrument / Assay)

Table 2-5

POC Tests – Ranked by Estimated Volume (2014)

Table 2-6

Types of Inhalants

Table 2-7

Annual Prevalence and Number of Illicit Drug Users Globally by Drug Type 2012

Table 2-8

Estimated Number and Prevalence of Drug Users by Region

Table 2-9

World Population by Selected Geographical Region, 2010 – 2050 (Africa, Asia,

Europe, Northern America, Oceania, Latin America and the Caribbean, World)

Figure 2-1

World Population by Selected Geographical Region, 2010–2050 (Africa, Asia, Europe,

Northern America, Oceania, Latin America and Caribbean)

Table 2-10

Estimated World Population by Age (0-14, 15-64, 65+, Men, Women, Total) and

Geographical Region (Africa, Asia, Europe, Northern America, Oceania, Latin

America and Caribbean, World), 2012

Figure 2-2

Estimated World Population by Age (0-14, 15-64, 65+) and Geographical Region(Africa, Asia, Europe, Northern America, Oceania, Latin America), 2012

Table 2-11

Percent Population Over 65 by Year and Region, 2010-2050 (Africa, Asia, Europe,

Northern America, Oceania, Latin America and the Caribbean, World)

Figure 2-3

Estimated World Population by Age, 2010 and 2050 (0-14, 15-64, 65+)

THREE: POC BLOOD GLUCOSE TESTS

Table 3-1

Selected Glucose Self-Test Meter Innovations

Table 3-2

Selected Apps and Glucose Management IT

Table 3-3

Selected Noninvasive Glucose Monitoring Devices

Table 3-4

Selected Continuous BGM Sales, 2014

Table 3-5

Selected Continuous Blood Glucose System Developments, 2014

Table 3-6

Selected POC HbA1c Devices

Table 3-7

Selected Innovations in POC Hospital-based Glucose Monitoring

Table 3-8

Global POC Glucose Testing Market Analysis: 2012-2019

Figure 3-1

Global POC Glucose Testing Market Analysis: 2012-2019

Table 3-9

Global POC Glucose Self-Testing Market Analysis, 2014 and 2019

Table 3-10

Global POC Glucose Professional Testing Market Analysis, 2014 and 2019

Table 3-11

Global POC Blood Glucose Testing Market Revenues and Market Share of Leading

Suppliers, 2014

Figure 3-2

Global POC Glucose Test Manufacturers by Percent, 2014

FOUR: POC BLOOD AND ELECTROLYTES TESTING MARKET

Table 4-1

Selected POC Hemoglobin and Hematocrit Systems, 2014

Table 4-2

Selected POC Hematology Analyzer Systems, 2014

Table 4-3

Global POC Blood and Electrolytes Testing Market Analysis: 2012-2019

Figure 4-1

Global POC Blood and Electrolytes Testing Market Analysis: 2012-2019

Table 4-4

Global POC Blood and Electrolyte Professional Testing Market Analysis, 2014 andm2019

Table 4-5

Global POC Blood and Electrolyte Testing Market Revenues and Market Share of Leading Suppliers, 2014

Figure 4-2

Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2014

FIVE: RAPID COAGULATION

Table 5-1

Selected POC Coagulation Innovations

Table 5-2

Selected Platelet Activity Test Innovations

Table 5-3

Global Rapid Coagulation Testing Market Analysis: 2012-2019

Figure 5-1

Global Rapid Coagulation Testing Market Analysis: 2012-2019

Table 5-4

POC Rapid Coagulation Self-Testing Market Analysis, 2014 and 2019

Table 5-5

POC Rapid Coagulation Professional Testing Market Analysis, 2014 and 2019

Table 5-6

Global POC Rapid Coagulation Testing Market Revenues and Market Share of

Leading Suppliers, 2014

Figure 5-2

Global POC Rapid Coagulation Testing Manufacturers by Percent, 2014

SIX: POC RAPID CARDIAC MARKERS

Table 6-1

Total Rapid Cardiac Markers Tests Market Analysis, 2012-2019

Figure 6-1

Global POC Rapid Cardiac Markers Test Market Analysis, 2012-2019

Table 6-2

Global POC Cardiac Markers Test Market Revenues and Market Share of Leading Suppliers, 2014

Figure 6-2

Global POC Cardiac Test Manufacturers by Percent, 2014

SEVEN: POC SUBSTANCE ABUSE TESTING

Table 7-1

Global POC Drugs of Abuse Testing Market Analysis: 2012-2019

Figure 7-1

Global POC Drugs of Abuse Testing Market Analysis: 2012-2019

Table 7-2

Global POC Drugs of Abuse Self-Testing Market Analysis, 2014 and 2019

Table 7-3

Global POC Drugs of Abuse Professional Testing Market Analysis, 2014

and 2019

Table 7-4

Global POC Drugs of Abuse Testing Market Revenues and Market Share of Leading

Suppliers, 2014

Figure 7-2

Global POC Drug of Abuse Testing Manufacturers by Percent, 2014

EIGHT: POC PREGNANCY AND FERTILITY TESTING

Table 8-1

2014 Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay)

Table 8-2

Global POC Pregnancy and Fertility Testing Market Analysis: 2012-2019

Figure 8-1

Global POC Pregnancy and Fertility Testing Market Analysis: 2012-2019

Table 8-3

POC Pregnancy and Fertility Self-Testing Market Analysis, 2014 and 2019

Table 8-4

POC Pregnancy and Fertility Professional Testing Market Analysis, 2014 and 2019

Table 8-5

Global POC Pregnancy and Fertility Testing Market Revenues and Market Share of Leading Suppliers, 2014

Figure 8-2

Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2014

NINE: POC COLON CANCER SCREENING/FECAL OCCULT BLOOD TESTING

Table 9-1

Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis:

2012-2019

Figure 9-1

Global POC Colon Cancer Screening/ Fecal Occult Blood Testing Market Analysis:

2012-2019

Table 9-2

POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis,2014 and 2019

Table 9-3

POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2014 and 2019

Table 9-4

Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Revenues and Market Share of Leading Suppliers, 2014

Figure 9-2

Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers by Percent, 2014

TEN: POC INFECTIOUS DISEASE TESTING

Table 10-1

Selected Professional-Use POC Tests for Infectious Diseases

Table 10-2

Global POC Infectious Disease Testing Market Analysis: 2012-2019

Table 10-3

POC Infectious Disease Self-Testing Market Analysis, 2014 and 2019

Table 10-4

POC Infectious Disease Professional Testing Market Analysis, 2014 and 2019

Table 10-5

Global POC Infectious Disease Testing Market Revenues and Market Share of

Leading Suppliers, 2014

Figure 10-2

Global POC Infectious Disease Test Manufacturers by Percent 2014

ELEVEN: POC CHOLESTEROL TESTING

Table 11-1

Global POC Cholesterol Testing Market Analysis: 2012-2019

Figure 11-1

Global POC Cholesterol Testing Market Analysis: 2012-2019

Table 11-2

POC Cholesterol Self-Testing Market Analysis, 2014 and 2019

Table 11-3

POC Cholesterol Professional Testing Market Analysis, 2014 and 2019

Table 11-4

Global POC Cholesterol Testing Market Revenues and Market Share of Leading

Suppliers, 2014

Figure 11-2

Global POC Cholesterol Testing Manufacturers by Percent, 2014

TWELVE: POC CANCER TESTING

Table 12-1

Selected Companies Developing and/or Marketing POC Tests for Hematology/Oncology Indications

Table 12-2

Global POC Cancer Testing Market Analysis: 2012-2019

Figure 12-1

Global POC Cancer Testing Market Analysis: 2012-2019

Table 12-3

Global POC Cancer Testing Market Revenues and Market Share of Leading

Suppliers, 2014

Figure 12-2

Global POC Cancer Testing Manufacturers by Percent, 2014

THIRTEEN: POC URINE STRIP TESTING

Table 13-1

Selected Dipstick Urinalysis Systems, 2014

Table 13-2

Global POC Urine Strip Testing Market Analysis: 2012-2019

Figure 13-1

Global POC Urine Strip Testing Market Analysis: 2012-2019

Table 13-3

POC Urine Strip Self-Testing Market Analysis, 2014 and 2019

Table 13-4

POC Urine Test Strip Professional Testing Market Analysis, 2014 and 2019

Table 13-5

Global POC Urine Strip Testing Market Revenues and Market Share of Leading

Suppliers, 2014

Figure 13-2

Global POC Urine Strip Testing Manufacturers by Percent, 2014

FOURTEEN: MISCELLANEOUS POC TESTING

Table 14-1

Global Miscellaneous POC Testing Market Analysis: 2012-2019

Figure 14-1

Global Miscellaneous POC Testing Market Analysis: 2012-2019

FIFTEEN: ISSUES AND TRENDS

Table 15-1

Selected Biochip and Biosensor Players, 2014

Table 15-2

Selected Disease Markers in Exhaled Breath (Asthma, Breast cancer, Diabetes, Liver function, Lung cancer, Organ rejection, Renal function, Schizophrenia, Gastrointestinal malabsorption / Irritable Bowel Syndrome (IBS) / Celiac disease and food

intolerances / Bacterial overgrowth, Bacterial infection)

SIXTEEN: TOTAL GLOBAL POC TESTING MARKET AND

COMPETITOR ANALYSIS

Table 16-1

Global POC Testing Market Analysis: 2012-2019

Figure 16-1

Global POC Testing Market Analysis: 2012-2019

Table 16-2

Global POC Testing Market Analysis by Product Category, 2014 (Professional,

Self-Testing, Total)

Figure 16-2

Global POC Testing Market Analysis by Product Category, 2014 (Self-Test,

Professional)

Table 16-3

Global POC Professional Testing Market Analysis by Product Subcategory, 2014(Drugs of Abuse, Blood & Electrolytes, Glucose, Infectious Disease, Rapid Coagulation, Cardiac Markers, Fecal Occult Blood, Cholesterol, Pregnancy & Fertility, Miscellaneous, Urine Strip, Cancer, Total)

Figure 16-3

Global POC Professional Market Analysis by Product Subcategory, 2014 (Blood, DOA)

Table 16-4

Global POC Self-Testing Market Analysis by Product Category, 2014 (Glucose,

Pregnancy & Fertility, Fecal Occult Blood, Raid Coagulation, Drugs of Abuse, Urine Strip, Infectious Disease, Cholesterol, Total)

Figure 16-4

Global POC Self-Testing Market Analysis by Product Category, 2014 (PG, Glucose)

Table 16-5

Number of POCs in the United States (Compliance [Moderate and High Complexity], Waiver, Provider-Perfomed Microscopy [PPM], Accreditation [Moderate and High Complexity]) (2005-2013)

Table 16-6

Global POC Testing Market Analysis by Region/Country, 2014 (United States, Europe, Japan, ROW, Total)

Figure 16-5

Global POC Testing Market Analysis by Region/Country, 2014 (US, Europe, Japan, ROW)

Figure 16-6

Global POC Testing Market Analysis by Region/Country, 2019 (US, Europe, Japan, ROW)

Table 16-7

Global EU POC Testing Market Analysis by European Region, 2014(EU W. Europe, EU E. Europe)

Figure 16-7

Global EU POC Testing Market Analysis by European Region, 2014(W. Europe, E. Europe)

Table 16-8

Global POC Testing Market Analysis by Rest of World Region/Country, 2014(China, India, Brazil, Others, Total)

Figure 16-8

Global POC Testing Market Analysis by Rest of World Region/Country, 2014(China, India, Brazil, Others)

Table 16-9

Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2014

Figure 16-9

Global POC Testing Market Share by Leading Suppliers, 2014

SEVENTEEN: CORPORATE PROFILES

Figure 17-1

Abaxis Medical Revenues 2012-2014

Figure 17-2

Abbott Laboratories Revenues 2012-2014

Figure 17-3

Alere Laboratories Revenues 2012-2014

Figure 17-4

Danaher Life Sciences and Diagnostic Businesses Revenues 2012-2014

Figure 17-5

bioMerieux Revenues 2012-2014

Figure 17-6

Church & Dwight Revenues 2012-2014

Figure 17-7

Eiken Chemical Revenues 2012-2014

Figure 17-8

EKF Diagnostics Revenues 2012-2014

Figure 17-9

LifeScan Revenues 2012-2014

Figure 17-10

Meridian BioScience Revenues 2012-2014

Figure 17-11

OPKO Health Revenues 2012-2014

Figure 17-12

OraSure Revenues 2012-2014

Figure 17-13

Quidel Revenues 2012-2014

Figure 17-14

Response Biomedical Revenues 2012-2014

Figure 17-15

Roche Diagnostics Revenues 2012-2014

Figure 17-16

Siemens Revenues 2012-2014

Figure 17-17

Sysmex Revenues 2012-2014

Figure 17-18

Trinity Biotech Revenues 2012-2014

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Synthetic Blood Substitutes and Blood Products – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Cell Culture: The Market for Media, Sera and ReagentsGlobal Wound Care Markets: Forecasts to 2019 (Twelve Country Analysis: Germany,...
Scroll to top